Tue, September 14, 2021
Mon, September 13, 2021
Fri, September 10, 2021
Thu, September 9, 2021
Wed, September 8, 2021
Tue, September 7, 2021
Fri, September 3, 2021
Thu, September 2, 2021
Wed, September 1, 2021
Tue, August 31, 2021
Mon, August 30, 2021
Fri, August 27, 2021

Matthew Harrison Maintained (ADCT) at Buy with Decreased Target to $47 on, Sep 7th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-47-on-sep-7th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Harrison of Morgan Stanley, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Decreased Target from $51 to $47 on, Sep 7th, 2021.

Matthew has made no other calls on ADCT in the last 4 months.



There are 3 other peers that have a rating on ADCT. Out of the 3 peers that are also analyzing ADCT, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Kennen MacKay of "RBC Capital" Initiated at Buy and Held Target at $33 on, Monday, August 9th, 2021
  • Brian Cheng of "Cantor Fitzgerald" Initiated at Buy and Held Target at $46 on, Tuesday, June 15th, 2021
  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $55 on, Friday, May 14th, 2021